Jason C. Jones's most recent trade in Ekso Bionics Holdings Inc was a trade of 1,320 Common Stock done at an average price of $9.3 . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.25 per share. | 06 Jan 2026 | 1,320 | 25,621 (0%) | 0% | 9.3 | 12,210 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 09 Dec 2025 | 270 | 26,941 (0%) | 0% | 4.7 | 1,269 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 4.80 per share. | 10 Nov 2025 | 9,723 | 27,211 (0%) | 0% | 4.8 | 46,670 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2025 | 15,000 | 36,934 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 24,248 | 47,113 (0%) | 0% | - | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2024 | 7,474 | 22,865 (0%) | 0% | - | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 08 May 2023 | 3,435 | 138,554 (0%) | 0% | 1.6 | 5,401 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | Senior VP Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2022 | 17,007 | 141,989 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Senior VP Product Development | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 16 Nov 2022 | 782 | 124,982 (0%) | 0% | 1.3 | 1,003 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | Senior VP Product Development | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 31 Aug 2022 | 5,873 | 125,764 (0%) | 0% | 2.3 | 13,587 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | VP of Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 50,000 | 131,637 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | VP of Product Development | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 22 Mar 2022 | 3,265 | 81,637 (0%) | 0% | 2.8 | 9,206 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | VP of Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 13,760 | 84,902 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 10,800 | 15,391 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,446 | 4,591 (0%) | 0% | 0 | Common Stock |